These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33070280)

  • 1. Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data.
    Akechi T; Fujimoto S; Mishiro I; Murase K
    Clin Drug Investig; 2020 Dec; 40(12):1115-1125. PubMed ID: 33070280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database.
    Yamato K; Inada K; Enomoto M; Marumoto T; Takeshima M; Mishima K
    BMC Psychiatry; 2021 Jan; 21(1):40. PubMed ID: 33441086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world treatment patterns of patients with major depressive disorder treated with Auvelity in the United States.
    Muzyk A; Syed FZ; Zhou H; Cong J; Tabuteau H; Zhao Y
    J Med Econ; 2024; 27(1):1003-1010. PubMed ID: 39042111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).
    Keyloun KR; Hansen RN; Hepp Z; Gillard P; Thase ME; Devine EB
    CNS Drugs; 2017 May; 31(5):421-432. PubMed ID: 28378157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of major depressive disorder in Japanese cancer patients: A matched cohort study using employer-based health insurance claims data.
    Akechi T; Mishiro I; Fujimoto S; Murase K
    Psychooncology; 2020 Oct; 29(10):1686-1694. PubMed ID: 32779276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
    Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
    CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic prescription patterns among patients diagnosed with depressive disorder based on claims database in Japan.
    Onishi Y; Hinotsu S; Furukawa TA; Kawakami K
    Clin Drug Investig; 2013 Aug; 33(8):597-605. PubMed ID: 23842725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting persistence to antidepressant treatment in administrative claims data: Considering the influence of refill delays and prior persistence on other medications.
    Bushnell GA; Stürmer T; White A; Pate V; Swanson SA; Azrael D; Miller M
    J Affect Disord; 2016 May; 196():138-47. PubMed ID: 26921866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melancholic features in major depression - a European multicenter study.
    Dold M; Bartova L; Fugger G; Kautzky A; Mitschek MMM; Fabbri C; Montgomery S; Zohar J; Souery D; Mendlewicz J; Serretti A; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110285. PubMed ID: 33609603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants reduce the risk of suicide among elderly depressed patients.
    Barak Y; Olmer A; Aizenberg D
    Neuropsychopharmacology; 2006 Jan; 31(1):178-81. PubMed ID: 16123751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription patterns following first-line new generation antidepressants for depression in Japan: a naturalistic cohort study based on a large claims database.
    Furukawa TA; Onishi Y; Hinotsu S; Tajika A; Takeshima N; Shinohara K; Ogawa Y; Hayasaka Y; Kawakami K
    J Affect Disord; 2013 Sep; 150(3):916-22. PubMed ID: 23721923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study.
    Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S
    Eur Neuropsychopharmacol; 2020 Dec; 41():70-80. PubMed ID: 33046351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study.
    Saragoussi D; Chollet J; Bineau S; Chalem Y; Milea D
    Int J Clin Pract; 2012 Nov; 66(11):1079-87. PubMed ID: 23067031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of sedative-hypnotics in patients with recurrent major depressive disorder: a nationwide population-based 14-year follow-up study in Taiwan.
    Chung KH; Lee TY; Chung MH
    Psychopharmacology (Berl); 2021 Jun; 238(6):1553-1561. PubMed ID: 33630108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review.
    Blumberg MJ; Vaccarino SR; McInerney SJ
    J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32726521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant treatment and risk of dementia: a population-based, retrospective case-control study.
    Lee CW; Lin CL; Sung FC; Liang JA; Kao CH
    J Clin Psychiatry; 2016 Jan; 77(1):117-22; quiz 122. PubMed ID: 26845268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People's Republic of China.
    Zhang L; Chen Y; Yue L; Liu Q; Montgomery W; Zhi L; Wang W
    Neuropsychiatr Dis Treat; 2016; 12():941-9. PubMed ID: 27143895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment.
    Ball S; Classi P; Dennehy EB
    Ann Gen Psychiatry; 2014 Mar; 13(1):8. PubMed ID: 24645830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription patterns of antidepressants: findings from a US claims database.
    Milea D; Verpillat P; Guelfucci F; Toumi M; Lamure M
    Curr Med Res Opin; 2010 Jun; 26(6):1343-53. PubMed ID: 20373875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.